
Aggressive cost competition and the continuing growth of generic substitution will separate retailers’ interests from manufacturers’

Aggressive cost competition and the continuing growth of generic substitution will separate retailers’ interests from manufacturers’

The desire to compare drugs’ efficacy is shifting from a purely medical decision to a financial one

FDA counters that the PMC program balances drug efficacy study with patient need

Annual surveys rank public companies by environmental, social criteria

Suspicious Order Monitoring (SOMLink) tracks ordering history with statistical analysis of baseline activity


The desire to compare drugs’ efficacy is shifting from a purely medical decision to a financial one

Globaltrackandtrace.org will try to build industry consensus on pharma security, traceability

European Court of Justice affirms a lower-court decision in a case dating to 1998

Though stem cells and other regenerative medicine techniques hold enormous promise, they also face an equally large set of obstacles, ranging from research funding to reimbursement

Under the theme of personalized medicine, in vitro diagnostics will play an increasingly important role in new drug entries and new therapies

Better internal collaboration within companies is critical to improving the vital physician-rep relationship


As legislative mandates have receded, manufacturers must undertake their own initiatives for protecting against counterfeits and diversion

Specific, technology-based anticounterfeiting measures are a tactical response to a strategic problem. Holistic prevention strategies are needed

Blister card container has consumer-friendly features

Industry survey shows strengths and weaknesses of current IT support of supply chains

How to correlate plant performance to business performance

With new serialization-software release, Systech promotes ‘near-line’ applications

Oncology drug development pipelines are overflowing, but the sky-high prices of these agents are turning reimbursement schemes, and the very practice of cancer medicine, on their heads

CDC is depending on a new distribution process for ‘the largest vaccine distribution in history’

At 28% pharmaceutical sales, chain pharmacy still represents the single largest channel for delivering prescriptions to patients

Conventional training of sales forces is being complemented by executive-level training for corporate compliance


A collaborative working relationship gives launch day a better chance at success


ICANN asserts independence from worldwide governments

MarkMonitor sees 23% growth in offshore business exchanges for bulk pharmaceuticals and APIs

‘Managed Market Delegates on Demand’ is one; ‘Ask IMS’ is the other

Used for analyzing incoming raw materials, the technology also serves product authentication purposes